COMMUNIQUÉS West-GlobeNewswire

Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis

30/04/2025 - 14:30

– Pearce joins NHL Hall-of-Famer, Henrik Lundqvist, to educate patients and caregivers about the importance of accurate and early diagnosis of recurrent pericarditis, a chronic autoinflammatory disease of the heart that [...]

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

30/04/2025 - 14:30

VANCOUVER, British Columbia, April 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence [...]

Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025

30/04/2025 - 14:30

TAMPA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (NYSE American: SRXH) (“Better Choice” or the “Company”), a leading global health and wellness company, today announced [...]

Bioma Probiotics Reviews: Best Probiotic For Gut Health & Weight Loss Ingredients & Side Effects

30/04/2025 - 14:36

Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- In the present health-aware world, probiotics have become a pillar for the upkeep of gut health and general well-being. Among the numerous choices out there, Bioma [...]

Magnesium Breakthrough Under Review: Does BiOptimizers Magnesium Breakthrough Work? Best Magnesium Supplements!

30/04/2025 - 14:42

Find out why BiOptimizers Magnesium Breakthrough is consistently rated one of the best magnesium supplements by experts and real users. Albany, New York, April 30, 2025 (GLOBE NEWSWIRE) -- Stress is responsible for a [...]

PharmAla Issues Q2 Financial Statements

30/04/2025 - 14:55

TORONTO, April 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting

30/04/2025 - 15:00

MDNA113 is a novel IL-13Rα2 tumor-targeted and “masked” anti-PD-1-IL-2 Superkine (anti-PD1-IL-2 SK ), engineered to precisely deliver clinically validated anti-PD1 and IL-2 SK to the tumor microenvironment (TME) IL- [...]

Helius Medical Technologies Announces Reverse Stock Split

30/04/2025 - 15:00

NEWTOWN, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for [...]

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

30/04/2025 - 15:00

MIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced [...]

Senti Bio to Present at the Citizens JMP Life Sciences Conference

30/04/2025 - 15:00

Live video webcast presentation on Thursday, May 8 th at 1:00 PM ET Presentation will highlight the recently announced positive preliminary clinical results of lead program, SENTI-202, in the treatment of patients with [...]

Notice of Annual General Meeting 2025

30/04/2025 - 10:00

Oslo, Norway, 30 April 2025 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park on 22 May 2025 at 10:00am (CEST). The notice and proposed [...]

DEBRICHEM® Wins 2025 IIWCG Achievement Award for Innovation in Wound Care

30/04/2025 - 10:00

Recognized for Advancing Global Wound Care Through Innovation and Efficacy AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, the flagship product of DEBx Medical has been awarded the IIWCG Achievement Award 2025 [...]

DEBRICHEM® se voit décerner le prix 2025 IIWCG Achievement Award récompensant l’innovation dans le domaine du soin des plaies

30/04/2025 - 10:00

Reconnu pour ses avancées dans le domaine des soins des plaies à l’échelle mondiale grâce à son caractère innovant et à son efficacité AMSTERDAM, 30 avr. 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, le produit phare de DEBx [...]

Mountainside Joins Northwell Direct Network to Offer Best-in-Class Addiction Treatment

30/04/2025 - 11:47

NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Mountainside Treatment Center is pleased to be named an in-network provider with Northwell Direct, owned by Northwell Health, New York State’s largest healthcare provider and [...]

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for Breast Cancer Patients

30/04/2025 - 12:00

This collaboration will provide early-stage HER2-positive breast cancer patients with access to the targeted therapy that can reduce the risk of cancer recurrence and spread ATHENS, Greece and LOS ANGELES, April 30, [...]

Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

30/04/2025 - 06:15

Singapore , April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) , today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider [...]

Idorsia announces financial results for the first quarter 2025 – QUVIVIQ taking off in Europe and TRYVIO REMS removal increases the value of this outstanding asset

30/04/2025 - 07:00

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – April 30, 2025 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2025. Business highlights Q1 2025 QUVIVIQ™ ( [...]

Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed

30/04/2025 - 07:00

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Q1 2025 net sales of USD 2,480 million up by 3% in constant currencies (cc); stable in USD up by 5%[1] at a comparable growth rate ( [...]

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

30/04/2025 - 07:00

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 30, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small [...]